Latest News

Scientists ID compounds that target amyloid fibrils in Alzheimer's, other brain diseases

Scientists report an advance toward "structure-based drug design," with the potential to delay or treat Alzheimer's disease, Parkinson's disease, type II diabetes, ALS (also known as Lou Gehrig's disease) and many other degenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • 'Off switch' for pain discovered: Activating the adenosine A3 receptor subtype is key to powerful pain relief

  • Full-day preschool linked with increased school readiness compared with part-day

  • Diagnosing deafness early will help teenagers' reading development

  • Why do people with autism see faces differently?

  • Sportswomen still second best to sportsmen, in the press

  • Inpatient psychotherapy is effective in Germany

  • How various brain areas interact in decisions

  • Pleasure at another's misfortune is evident in children as young as two

  • Isolation of important centres in brain results in age-related memory deficits

  • Prehistoric conflict hastened human brain's capacity for collaboration

  •